CAS Number41340-25-4
SynonymsEtodolac; 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid; etodolic acid; etodolacum [INN_la]; Ultrado; Etodolac [USAN:BAN:INN]; Lodine; Hypen; Tedolan; Zedolac; Etodlic acid; Edolan; MFCD00133313; RAK-591; Ramodar; (1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid
Molecular FormulaC17H21NO3
Molecular Weight287.35
Purity98%
Density1.2±0.1 g/cm3
Boiling Point507.9±45.0 °C at 760 mmHg
Melting Point145-1480C
Appearancecrystalline solid
Symbol
Signal WordWarning
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 41340-25-4 |
| Catalog No. | 2A-9010417 |
| Chinese Name | 依托度酸 |
| Synonyms | Etodolac; 1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid; etodolic acid; etodolacum [INN_la]; Ultrado; Etodolac [USAN:BAN:INN]; Lodine; Hypen; Tedolan; Zedolac; Etodlic acid; Edolan; MFCD00133313; RAK-591; Ramodar; (1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic acid |
| Molecular Formula | C17H21NO3 |
| Molecular Weight | 287.35 |
| Purity | 98 |
| Density | 1.2±0.1 g/cm3 |
| Boiling Point | 507.9±45.0 °C at 760 mmHg |
| Melting Point | 145-1480C |
| Appearance | crystalline solid |
| Water Solubility | Soluble in: methanol |
| Storage Condition | Seal and store at 2ºC -8ºC |
| Packaging | III |
| Application | Etodolac is a non-steroidal anti-inflammatory compound with an IC50 of 53.5 nM for COX. |
| HTC | 2934999090 |
| PubChem ID | 24278407 |
| MDL Number | MFCD00133313 |
| SMILES | CCc1cccc2c3CCOC(CC)(CC(O)=O)c3[nH]c12 |
| InChI | 1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20) |
| InChI Key | NNYBQONXHNTVIJ-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| Hazard Symbols | 6.1(b) |
| MSDS | msds/10417_1_41340_25_4.pdf |
| Bioactivity | Etodolac is a non-steroidal anti-inflammatory compound that is a non-selective inhibitor of COX (IC50=53.5 nM)IC50 value: 53.5 nMTarget: COX1; COX2Post-marketing studies demonstrated that etodolac inhibition of cyclooxygenase is somewhat COX-2 selective similar to celecoxib and other "COX-2 inhibitors." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated as having "preferential selectivity" toward COX-2. The (inactive against COX) r-enantiomer of etodolac inhibits beta-catenin levels in hepatoma cells. Related Catalog Research Areas >> Inflammation/Immunology Target COX-2:41 nM (IC50, in CHO cells) COX-1:∼50000 nM (IC50, in CHO cells) References [1]. Riendeau D, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121(1):105-17. [2]. Ito S, Tajima K, Nogawa M et al. Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia. J Pharmacol Exp Ther. 2012 Jul;342(1):53-60. [3]. Yanaoka K, Oka M, Yoshimura N et al. Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion. Int J Cancer. 2010 Mar 15;126(6):1467-73. [4]. Matsuyama M, Yoshimura R, Hase T et al. Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model. Mol Med Report. 2010 Sep-Oct;3(5):771-4. Chemical & Physical Properties Density 1.2±0.1 g/cm3 Boiling Point 507.9±45.0 °C at 760 mmHg Melting Point 145-1480C Molecular Formula C17H21NO3 Molecular Weight 287.353 Flash Point 261.0±28.7 °C Exact Mass 287.152130 PSA 62.32000 LogP 3.59 Vapour Pressure 0.0±1.4 mmHg at 25°C Index of Refraction 1.597 InChIKey NNYBQONXHNTVIJ-UHFFFAOYSA-N SMILES CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3 Storage condition 2-8°C |
| Use of | Etodolac is a non-steroidal anti-inflammatory compound that is a non-selective inhibitor of COX (IC50=53.5 nM)IC50 value: 53.5 nMTarget: COX1; COX2Post-marketing studies demonstrated that etodolac inhibition of cyclooxygenase is somewhat COX-2 selective similar to celecoxib and other "COX-2 inhibitors." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated as having "preferential selectivity" toward COX-2. The (inactive against COX) r-enantiomer of etodolac inhibits beta-catenin levels in hepatoma cells. Properties Articles48 Name etodolac Synonym More Synonyms Etodolac Biological Activity Description Etodolac is a non-steroidal anti-inflammatory compound that is a non-selective inhibitor of COX (IC50=53.5 nM)IC50 value: 53.5 nMTarget: COX1; COX2Post-marketing studies demonstrated that etodolac inhibition of cyclooxygenase is somewhat COX-2 selective similar to celecoxib and other "COX-2 inhibitors." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated as having "preferential selectivity" toward COX-2. The (inactive against COX) r-enantiomer of etodolac inhibits beta-catenin levels in hepatoma cells. Related Catalog Research Areas >> Inflammation/Immunology COX-2:41 nM (IC50, in CHO cells) COX-1:∼50000 nM (IC50, in CHO cells) References [1]. Riendeau D, et al. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br J Pharmacol. 1997 May;121(1):105-17. [2]. Ito S, Tajima K, Nogawa M et al. Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mouse model of mechanical allodynia. J Pharmacol Exp Ther. 2012 Jul;342(1):53-60. [3]. Yanaoka K, Oka M, Yoshimura N et al. Preventive effects of etodolac, a selective cyclooxygenase-2 inhibitor, on cancer development in extensive metaplastic gastritis, a Helicobacter pylori-negative precancerous lesion. Int J Cancer. 2010 Mar 15;126(6):1467-73. [4]. Matsuyama M, Yoshimura R, Hase T et al. Administration of the selective cyclooxygenase (COX)-2 inhibitor etodolac prolongs cardiac allograft survival in a mouse model. Mol Med Report. 2010 Sep-Oct;3(5):771-4. Chemical & Physical Properties Molecular Formula C17H21NO3 Exact Mass 287.152130 PSA 62.32000 Index of Refraction 1.597 InChIKey NNYBQONXHNTVIJ-UHFFFAOYSA-N |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Purity: 98.0% |
| MSDS Transport Info | Module 14. Shipping information 14.1 UN dangerous goods number European Dangerous Regulations for land transport: 2811 International Dangerous Regulations for sea transport: 2811 International Dangerous Regulations for air transport: 2811 14.2 Names specified by the United Nations (UN) European Land Transport Dangerous Regulations: TOXIC SOLID, ORGANIC, N.O.S. (Etodolac) IMDG: TOXIC SOLID, ORGANIC, N.O.S. (Etodolac) International air transport hazard regulations: Toxic solid, organic, n.o.s. (Etodolac) 14.3 Transport hazard categories European Land Transport Danger Regulations: 6.1 International Maritime Transport Danger Regulations: 6.1 International Air Transport Danger Regulations: 6.1 14.4 Package group European Land Transport Danger Regulations: III International Maritime Transport Danger Regulations: III International Air Transport Danger Regulations: III 14.5 Environmental hazards European Land Transport Dangerous Regulations: No International Maritime Transport Dangerous Regulations Maritime Pollutants: No International Air Transport Risk Regulations: No 14.6 Special reminder to users No data available |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| Etilefrine hydrochloride | 943-17-9 | 2A-9010412 |
| Etiracetam | 33996-58-6 | 2A-9010413 |
| Etiroxate | 17365-01-4 | 2A-9010414 |
| Etizolam | 40054-69-1 | 2A-0200212 |
| Etobenzanid | 79540-50-4 | 2A-9010416 |
| Etofenprox | 80844-07-1 | 2A-9010418 |
| Etofibrate | 31637-97-5 | 2A-9010419 |
| Etofylline clofibrate | 54504-70-0 | 2A-9010420 |
| Etomidate | 33125-97-2 | 2A-9010421 |
| Etomoxir | 82258-36-4 | 2A-9010422 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS